Barclays Maintains Overweight on MetLife, Raises Price Target to $111
Barclays analyst Alex Scott maintains MetLife (NYSE:MET) with a Overweight and raises the price target from $97 to $111.
What This Story Means
Claude is explaining the story in plain words…
Read the Full Story at the Source
The summary here comes from the news provider; the rest of the article lives on the publisher's site: Benzinga